The RIQAS (Randox International Quality Assessment Scheme) Liquid Cardiac Program is a monthly EQA program designed to monitor the performance of 10 clinically significant cardiac markers. Results are submitted on a monthly basis with sophisticated yet easy to interpret reports provided within 24-48 hours to enable any corrective actions to be taken as soon as possible.
• Liquid ready to use samples ideal for Point-of-Care testing • 100% human serum • All parameters present at clinically significant levels • Varied levels allow for superior evaluation of potential bias • Submit results quickly and easily online • Register up to 5 instruments at no extra cost.
Our extensive analyte menu allows for increased consolidation and cost savings.
Full List of Parameters BNP, CK-MB (Mass), D-Dimer, Digoxin, Homocysteine, hsCRP, Myoglobin, NT-proBNP, Troponin I and Troponin T
RIQAS is the largest international EQA scheme in the world with over 22,000 participants in more than 100 countries.
RIQAS Key Benefits • High quality samples • Flexible programme options • Accreditation to a number of internationally recognised standards including ILAC G13:2007 (ISO/IEC 17043) and ISO13485 • Unrivalled technical support via our team of RIQAS scientists and experts